Two FDA Approvals to Advance Migraine Care

October 1, 2024

Proactive Mitigation to Support Program Success



Learn how CRC’s proactive approach and real-time data oversight supported the FDA approvals of two novel migraine treatments. Download the full case study to discover the strategies CRC implemented to overcome challenges and ensure the successful capture of primary endpoint data at critical timepoints.

October 10, 2025
CRC team members share what drives their commitment to advancing mental health clinical research and supporting sponsors developing innovative psychiatric therapies.
September 29, 2025
This World Alzheimer’s Month, CRC shares the personal stories that power our mission in Alzheimer’s research and inspire our work as a neuroscience-focused CRO.
neural network
September 10, 2025
Why do neuropsychiatric trials fail? Experts Dr. Steve Brannan and Dr. David Walling share strategies to protect investments in neuropsychiatric drug development.
Show More